Comment: Usefulness of herbal and dietary supplement references [5]

Annals of Pharmacotherapy

Volumn 37, Issue 9, 2003, Pages 1346-

  Burnakis, Thomas G ^a  

^a BAPTIST MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT; IMATINIB; IRINOTECAN;

DIET SUPPLEMENTATION; DRUG SAFETY; DRUG USE; HYPERICUM PERFORATUM; LETTER; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TRADITIONAL MEDICINE;

EID: 0041422283     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C046a     Document Type: Letter

References (6)

1. Sweet BV, Gay WE, Leady MA, Stumpf JL. Usefulness of herbal and dietary supplement references. Ann Pharmacother 2003;37:494-9. DOI 10.1345/aph.1C046
2. Package insert. Gleevec (imatinib mesylate). East Hanover, NJ: Novartis Pharmaceuticals Corporation, December 2002.
3. Mathijssen RH, Verweij J, de Bruijn P, Loos WJ, Sparreboom A. Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst 2002; 94:1247-9.
4. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18:2505-14.
5. Tasaki K, Maskarinec G, Shumay DM, Tatsumura Y, Kakai H. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives. Psychooncology 2002;11:212-20.
6. Ernst E. The risk-benefit profile of commonly used herbal therapies: ginkgo, St. John's wort, ginseng, saw palmetto, and kava. Ann Intern Med 2002;136:42-53.